Cytochrome P4502C9 induces cycloxygenase-2 expression in endothelial cells

被引：0
|
作者：
Michaelis, UR [1 ]
Fisslthaler, B [1 ]
Fleming, I [1 ]
Busse, R [1 ]
机构：
[1] Klinikum JWG Univ, Frankfurt, Germany
来源：
EUROPEAN HEART JOURNAL | 2003年 / 24卷
关键词：
D O I：
10.1016/S0195-668X(03)93694-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [41] Cytochrome P4502C9 polymorphisms (CYP2C9) and warfarin maintenance dose in elderly patients
    Siguret, V
    Gouin, I
    Golmard, JL
    Geoffroy, S
    Andreux, JP
    Pautas, E
    REVUE DE MEDECINE INTERNE, 2004, 25 (04): : 271 - 274
  • [42] Cytochrome P4502C9 (CYP2C9) gene polymorphism and safety off therapy with warfarin
    Mikheeva, Yu. A.
    Kropacheva, E. S.
    Ignatiev, I. V.
    Bulytova, Yu. M.
    Ramenskaya, G. V.
    Sytchev, D. A.
    Dobrovolsky, A. B.
    Panchenko, E. P.
    KARDIOLOGIYA, 2008, 48 (03) : 52 - 57
  • [43] Evaluation of cytochrome P4502C9 metabolic activity with tolbutamide in CYP2C9*1 heterozygotes
    Lee, CR
    Pieper, JA
    Hinderliter, AL
    Blaisdell, JA
    Goldstein, JA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (05) : 562 - 571
  • [44] Catalytic activities of human cytochrome P4502C9*1, 2C9*3 and 2C9*13
    Guo, Y
    Wang, Y
    Si, D
    Fawcett, PJ
    Zhong, D
    Zhou, H
    XENOBIOTICA, 2005, 35 (09) : 853 - 861
  • [45] Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase-2 in endothelial cells
    Michaelis, UR
    Falck, JR
    Schmidt, R
    Busse, R
    Fleming, I
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (02) : 321 - 326
  • [46] Ketobemidone is a substrate for cytochrome P4502C9 and 3A4, but not for P-glycoprotein
    Yasar, Ü
    Annas, A
    Svensson, JO
    Lazorova, L
    Artursson, P
    Al-Shurbaji, A
    XENOBIOTICA, 2005, 35 (08) : 785 - 796
  • [47] Modeling and synthesis of novel tight-binding inhibitors of cytochrome P4502C9
    Peng, Chi-Chi
    Rushmore, Tom
    Crouch, Gregory J.
    Jones, Jeffrey P.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (07) : 4064 - 4074
  • [48] Metabolites of cytochrome P4502C9 are not essential for the regulation of coronary vasomotor tone in swine
    Merkus, D
    Sorop, O
    Houweling, B
    Duncker, DJ
    FASEB JOURNAL, 2006, 20 (05): : A1399 - A1399
  • [49] Amino acid residues affecting the activities of human cytochrome P4502C9 and 2C19
    Niwa, T
    Kageyama, A
    Kishimoto, K
    Yabusaki, Y
    Ishibashi, F
    Katagiri, M
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (08) : 931 - 936
  • [50] Warfarin and cytochrome P4502C9 genotype: possible ethnic variation in warfarin sensitivity
    Kealey, Canel
    Chen, Zhen
    Christie, Jason
    Thorn, Caroline F.
    Whitehead, Alexander S.
    Price, Maureen
    Samaha, Frederick F.
    Kimmel, Stephen E.
    PHARMACOGENOMICS, 2007, 8 (03) : 217 - 225
12345